Search results
U.S. drug makers see big profits — but many pay taxes far below the corporate rate
WUSF 89.7· 2 weeks agoDrugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.
Pfizer to seek wider use of RSV shot after trial in young adults
The Day· 2 weeks agoPfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for ...
Drugmakers' low U.S. taxes belie their high sales
WUSF 89.7· 1 week agoWhile Americans are scrambling to file last minute returns, things are somewhat more complicated for corporations. Corporations are supposed to pay a...
The Smartest Dividend Stocks to Buy With $400 Right Now
Motley Fool via Yahoo Finance· 1 week agoI think so. The demand for oil and gas will likely grow even with increased renewable energy...
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
Motley Fool via Yahoo Finance· 3 days agoPfizer Pfizer (NYSE: PFE) has been a household name for a long time. The company ranks among the...
13 new obesity drugs could hit the market by 2029 amid surging demand (NYSE:NVO)
Seeking Alpha· 2 days agoDrugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the...
Will Biopharma Companies Shun Vaccine R&D In A New Pandemic?
Forbes· 2 weeks agoIn the spring of 2020, Covid-19 essentially shut down the U.S. as well as most of the rest of the...
Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say
Morningstar· 2 weeks agoNovo Nordisk and Eli Lilly & Co., the dynamic duo of the weight-loss drug world, still have plenty of upside even after their shares have surged over the past 12 months, BMO Capital Markets ...
Vax rivals head to the pharmacy
Politico· 4 days agoWilson reports. Many U.S. and European drugmakers rely on companies covered by the legislation, such as WuXi AppTec, during the research, development and manufacturing of ...
AbbVie retains Humira market despite copycats (NYSE:ABBV)
Seeking Alpha· 1 week agoDespite the entry of discounted biosimilars, AbbVie (ABBV) has maintained 96% market share for its...
